Works matching IS 00070963 AND DT 2025 AND VI 192 AND IP 3

Results: 43
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 3, p. 481, doi. 10.1093/bjd/ljae433
    By:
    • Placke, Jan-Malte;
    • Bottek, Jenny;
    • Váraljai, Renata;
    • Shannan, Batool;
    • Scharfenberg, Sarah;
    • Krisp, Christoph;
    • Spangenberg, Philippa;
    • Soun, Camille;
    • Siemes, Devon;
    • Borgards, Lars;
    • Hoffmann, Franziska;
    • Zhao, Fang;
    • Paschen, Anette;
    • Schlueter, Hartmut;
    • von Eggeling, Ferdinand;
    • Helfrich, Iris;
    • Rambow, Florian;
    • Ugurel, Selma;
    • Tasdogan, Alpaslan;
    • Schadendorf, Dirk
    Publication type:
    Article
    17

    Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 3, p. 551, doi. 10.1093/bjd/ljae432
    By:
    • van der Weyden, Louise;
    • Velasco-Herrera, Martin Del Castillo;
    • Cheema, Saamin;
    • Wong, Kim;
    • Boccacino, Jacqueline M;
    • Vermes, Ian;
    • Offord, Victoria;
    • Droop, Alastair;
    • Jones, David R A;
    • Anderson, Elizabeth;
    • Hardy, Claire;
    • Aubain, Nicolas de Saint;
    • Ferguson, Peter M;
    • Mogler, Carolin;
    • Rajan, Neil;
    • Frew, Derek;
    • Harms, Paul W;
    • Billings, Steven D;
    • Schatton, Désirée;
    • Segarra-Mondejar, Marc
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 3, p. 402, doi. 10.1093/bjd/ljae406
    By:
    • Zhang, Jianzhong;
    • Ding, Yangfeng;
    • Wang, Ping;
    • Li, Linfeng;
    • Pan, Weili;
    • Lu, Yan;
    • Cheng, Hao;
    • Jiang, Xian;
    • Ho, Ji-Chen;
    • Guo, Shuping;
    • Liu, Leona;
    • Chatterjee, Arkendu;
    • Kisa, Renata M;
    • Banerjee, Subhashis
    Publication type:
    Article
    34
    35

    Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 3, p. 501, doi. 10.1093/bjd/ljae403
    By:
    • Planella-Fontanillas, Nidia;
    • Bosch-Amate, Xavier;
    • Antón, Alicia Jiménez;
    • Moreno-Vílchez, Carlos;
    • Guerrero, María Gamo;
    • Martínez, María del Mar Blanes;
    • Martínez, María Asunción Ballester;
    • Bassas-Freixas, Patricia;
    • Fernández, Juan Luis Castaño;
    • Corrales, Andrea Estébanez;
    • Fernández, Ricardo Suarez;
    • Alarcón, Sergio Santos;
    • Alonso, Ana Bauzá;
    • Torrent, Marina;
    • Ruiz, Adrian Ballano;
    • Rodríguez, Cristina Collantes;
    • España, Agustín;
    • Capdevila, Eduardo Fonseca;
    • Faure, Inmaculada Gil;
    • Fernández, Carlos Pelayo Hernández
    Publication type:
    Article
    36
    37

    Trichomycosis axillaris.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 3, p. 557, doi. 10.1093/bjd/ljae397
    By:
    • Bao, Fangfang;
    • Wang, Shufen;
    • Chen, Chenchen;
    • Zhang, Yong;
    • Li, Jianke;
    • Liu, Xinzhou;
    • Zhang, Furen
    Publication type:
    Article
    38
    39
    40
    41
    42
    43